ASCO 2023: Integra Connect to Showcase how its Technology and Real-World Data are Helping Deliver on the Promise of Value-based, Precision Oncology

/PRNewswire/ -- Integra Connect, LLC., the leading provider of value-based, precision medicine solutions and services for specialty care, today announced that...

Related Keywords

United States ,American ,Parpi Monotherapy ,Jeffreya Scott ,Alyssa Howerton ,Garret Hampton ,Linkedin ,American Society Of Clinical Oncology ,Promising Tool For Community Practices ,Integra Connect ,Equality Initiative ,Health Services Research ,Population Health Solutions At Integra ,Thermo Fisher ,Clinical Oncology ,Annual Meeting ,Thermo Fisher Scientific ,Testing Advances Precision Oncology ,Decisions Impact End Of Life Patient Outcomes ,Machine Learning Technologies ,Promising Tool ,Community Practices ,Real World Data Delivers ,Evidence Based Decision Making ,Chief Medical Officer ,Population Health Solutions ,Fisher Scientific ,Integra Research Highlights Value ,Rapid Genomic ,World Testing ,Treatment Patterns Among Patients ,Small Cell Lung Cancer ,Retrospective Observational Study ,Session Title ,Lung Cancer ,Small Cell Metastatic ,Connect Pinpoints Ways ,Improve Patient Outcomes ,Oncology Care Model ,Quality Improvement ,Gynecologic Cancer ,Integra Connect Precision ,Oncology Care ,Organizations Utilize Integra Connect ,Value Based Care Focused Real World Data ,Advance Evidence Based Cancer ,World Outcomes ,First Line Maintenance ,Advanced Ovarian ,Polymerase Inhibitors ,Resistant Prostate Cancer ,Homologous Recombination Repair ,Ovarian Cancer Treated ,Line Maintenance ,Differences Related ,Treated Win Routine Care Settings ,